首页> 外国专利> method for the determination of the methylierungsgrades of certain cytosinen in genomic dna in sequenzkontext 5 '- 3' cpg

method for the determination of the methylierungsgrades of certain cytosinen in genomic dna in sequenzkontext 5 '- 3' cpg

机译:序列图5'-3'cpg中测定基因组DNA中某些胞嘧啶的甲基化等级的方法

摘要

Determining the degree of methylation of a particular cytosine in a motif 5'-CpG-3', present in a genomic sample of DNA (I), is new. Determining the degree of methylation of a particular cytosine in a motif 5'-CpG-3', present in a genomic sample of DNA (I), is new. The sample is treated chemically to convert cytosine (C), but not methylated C, to uracil, then part of (I) that contains the target C is amplified to form a labeled amplicon (II). (II) is hybridized to two classes, each with at least one member, of oligonucleotides and/or peptide-nucleic acid (PNA) oligomers (A) and the degree of hybridization to both classes is determined from the label on (II). From the ratio of labels hybridized to the two classes of (A), the degree of methylation is calculated. Independent claims are also included for the following: (1) a kit comprising a bisulfite, primer oligonucleotides for amplification, and/or (A), preferably immobilized on a solid phase, plus instructions; (2) a nucleic acid comprising at least 18 bases from chemically pretreated DNAs (B) of sequences (1) - (40712), not given in the specification; (3) oligonucleotide or PNA oligomers (OG) for use in the new process comprising a sequence of at least 9 nucleotides (nt) able to hybridize to (B); (4) sets of OG; (5) sets of at least two primer oligonucleotides for amplifying at least one (B) or its segment; (6) sets of oligonucleotide probes for determining the degree of C methylation and/or single nucleotide polymorphisms in (B), comprising at least ten OG; (7) preparing carrier-bound arrays of different OG for analysis of diseases associated with the methylation status of (B), by attaching OG to a solid phase; and (8) arrays made by (7).
机译:测定存在于DNA(I)基因组样品中的5'-CpG-3'基序中特定胞嘧啶的甲基化程度是新的。测定存在于DNA(I)基因组样品中的5'-CpG-3'基序中特定胞嘧啶的甲基化程度是新的。化学处理样品以将胞嘧啶(C)而不是甲基化的C转化为尿嘧啶,然后将包含目标C的部分(I)扩增以形成标记的扩增子(II)。 (II)与寡核苷酸和/或肽核酸(PNA)寡聚体(A)的两类杂交,每一种均具有至少一个成员,并且与这两类的杂交程度由(II)上的标记确定。从与两种(A)类别杂交的标记的比例,计算甲基化程度。还包括以下方面的独立权利要求:(1)试剂盒,包括亚硫酸氢盐,用于扩增的引物寡核苷酸,和/或(A),优选固定在固相上的试剂盒,以及说明书; (2)核酸,其包含来自序列(1)至(40712)的化学预处理的DNA(B)的至少18个碱基,在说明书中未给出; (3)用于新方法的寡核苷酸或PNA寡聚体(OG),其包含能够与(B)杂交的至少9个核苷酸(nt)的序列; (4)套OG; (5)用于扩增至少一个(B)或其片段的至少两种引物寡核苷酸组; (6)用于确定(B)中的C甲基化程度和/或单核苷酸多态性的寡核苷酸探针组,其包含至少十个OG; (7)通过将OG附着在固相上,制备用于分析与(B)的甲基化状态有关的疾病的不同OG的载体结合的阵列; (8)由(7)构成的数组。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号